BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 13992335)

  • 1. [Hydrotherapy in the home in chronic bladder and prostate diseases].
    SCHOLTZ HG
    Arch Phys Ther (Leipz); 1962; 14():391-2. PubMed ID: 13992335
    [No Abstract]   [Full Text] [Related]  

  • 2. Evaluation of interleukin-8 in expressed prostatic secretion as a reliable biomarker of inflammation in benign prostatic hyperplasia.
    Liu L; Li Q; Han P; Li X; Zeng H; Zhu Y; Wei Q
    Urology; 2009 Aug; 74(2):340-4. PubMed ID: 19464042
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Expression of estrogen receptor beta in benign prostatic hyperplasia complicated by chronic prostatitis].
    Yang GQ; Li SW; Zheng H; Zhang WB; Hu WL; Zheng XM
    Zhonghua Nan Ke Xue; 2009 Apr; 15(4):314-7. PubMed ID: 19472903
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [A clinical analysis of benign prostatic hyperplasia with chronic prostatitis].
    Wu XJ; Yang LY; Zhang XZ
    Zhonghua Nan Ke Xue; 2008 Jun; 14(6):527-9. PubMed ID: 18649752
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Role of apoptosis and chronic prostatitis in the pathogenesis of benign prostatic hyperplasia].
    Pawlicki B; Zieliński H; Dabrowski M
    Pol Merkur Lekarski; 2004 Oct; 17(100):307-10. PubMed ID: 15690689
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Prostatic retention cyst around the bladder neck: a case report].
    Shirakawa H; Kozakai N; Sugiura H; Hara S
    Hinyokika Kiyo; 2009 Sep; 55(9):583-6. PubMed ID: 19827624
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [One-stage transurethral resection of the urinary bladder and the prostate in patients with superficial cancer of the urinary bladder combined with benign prostatic hyperplasia].
    Karaguzhin SG; Merinov DS; Martov AG
    Urologiia; 2005; (5):17-21. PubMed ID: 16281833
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Diseases of the bladder neck gland, prostate].
    Haraldsson S
    Timarit Hjukrunarfel Isl; 1973; 49(1):20-3 passim. PubMed ID: 4121306
    [No Abstract]   [Full Text] [Related]  

  • 9. [Advances in researches on the relationship between prostatic diseases and erectile dysfunction].
    Zhan JC; Wei AY
    Zhonghua Nan Ke Xue; 2005 Jun; 11(6):462-5. PubMed ID: 15999496
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of intravesical potassium sensitivity test and bladder biopsy in patients with chronic prostatitis/chronic pelvic pain syndrome.
    Hassan AA; Elgamal SA; Sabaa MA; Salem K
    Int J Urol; 2007 Aug; 14(8):738-42. PubMed ID: 17681066
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Seminal plasma cytokines and chemokines in prostate inflammation: interleukin 8 as a predictive biomarker in chronic prostatitis/chronic pelvic pain syndrome and benign prostatic hyperplasia.
    Penna G; Mondaini N; Amuchastegui S; Degli Innocenti S; Carini M; Giubilei G; Fibbi B; Colli E; Maggi M; Adorini L
    Eur Urol; 2007 Feb; 51(2):524-33; discussion 533. PubMed ID: 16905241
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Optimizing the management of prostate diseases: prostatitis and benign prostatic hyperplasia. Introduction.
    Nickel JC; Roehrborn CG
    BJU Int; 2008 Mar; 101 Suppl 3():1. PubMed ID: 18307677
    [No Abstract]   [Full Text] [Related]  

  • 13. [Cases of bacillus Calmette-Guerin-induced granulomatous prostatitis and prostatic stromal invasion of the bladder carcinoma in situ, showing similar clinical findings].
    Okusa H; Irie A; Chin I; Baba S; Mitomi H; Shitara T
    Hinyokika Kiyo; 2003 Sep; 49(9):555-7. PubMed ID: 14598697
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Optimal treatment of benign prostatic hyperplasia (BPH) with comorbid chronic prostatitis (category IIIA)].
    Golubchikov VA; Sitnikov NV; Kochetov AG; Perekhodov SN; Sidorov OV; Roiuk RV; Nagoprniuk VN; Tsibizov DN
    Urologiia; 2005; (4):9-12. PubMed ID: 16158737
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Stimulating substitution therapy with tradon in the treatment of prostate diseases during the cure at a medicinal spring for kidney and bladder disorders].
    Feiber W
    Landarzt; 1964 Nov; 40(32):1399-400. PubMed ID: 4157558
    [No Abstract]   [Full Text] [Related]  

  • 16. [Experiences with raveron in the treatment of prostate hypertrophy and chronic prostatitis].
    KUNZ A
    Wien Klin Wochenschr; 1957 Feb; 69(7):124-5. PubMed ID: 13423256
    [No Abstract]   [Full Text] [Related]  

  • 17. K channel expression in prostate epithelium and its implications in men with chronic prostatitis.
    Liang CZ; Guo QK; Hao ZY; Yang S; Wang DB; Wu LX; Liu C; Wang KX; Zhang XJ
    BJU Int; 2006 Jan; 97(1):190-2. PubMed ID: 16336354
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of the phytotherapeutic agent Eviprostat on 17beta-estradiol-induced nonbacterial inflammation in the rat prostate.
    Oka M; Ueda M; Oyama T; Kyotani J; Tanaka M
    Prostate; 2009 Sep; 69(13):1404-10. PubMed ID: 19489033
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical approach to the prostate: an update.
    Kutikov A; Guzzo TJ; Malkowicz SB
    Radiol Clin North Am; 2006 Sep; 44(5):649-63, vii. PubMed ID: 17030218
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Zinc levels in prostatic fluid of patients with prostate pathologies].
    Gómez Y; Arocha F; Espinoza F; Fernández D; Vásquez A; Granadillo V
    Invest Clin; 2007 Sep; 48(3):287-94. PubMed ID: 17853788
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.